Article
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma
13 Nov 2024
Abstract excerpt
ABSTRACT: The determination of the genetic subtypes of primary central nervous system lymphoma (PCNSL) and their relationship to differential chemoimmunotherapeutic response has not been established. There is a particular need for genomic biomarkers that identify patients with newly diagnosed PCNSL at high risk of early progression and death. We applied targeted next-generation sequencing for detection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
